Studies

CellWell record HH-5447

Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease

Yong Y; Ding H; Fan Z; et al.

Neurochemical Research ยท 2011

In plain language

In a rat 6-hydroxydopamine model of Parkinson's disease, lithium treatment did not protect substantia nigra dopaminergic neurons from degeneration, suggesting GSK-3 is only minimally involved in this injury model.

Evidence
Emerging
Studied in
Human, Animal

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-5447

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.